Gene: RBM43
Official Full Name: RNA binding motif protein 43provided by HGNC
Gene Summary: Predicted to enable RNA binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14654 | RBM43 Knockout cell line (HeLa) | Human | RBM43 | 1:3~1:6 | Negative | Online Inquiry |
KO14655 | RBM43 Knockout cell line (HCT 116) | Human | RBM43 | 1:2~1:4 | Negative | Online Inquiry |
KO14656 | RBM43 Knockout cell line (HEK293) | Human | RBM43 | 1:3~1:6 | Negative | Online Inquiry |
KO14657 | RBM43 Knockout cell line (A549) | Human | RBM43 | 1:3~1:4 | Negative | Online Inquiry |
RBM43 Gene Knockout Cell Lines are engineered cellular systems that specifically disable the expression of the RBM43 gene, which has been implicated in various biological processes, including RNA metabolism, cellular stress responses, and developmental regulation. By utilizing CRISPR-Cas9 technology, these cell lines allow researchers to study the precise role of RBM43 in cellular physiology and disease pathology, offering a powerful tool for genetic exploration.
The primary mechanism of action in RBM43 Gene Knockout Cell Lines involves targeted deletion of specific DNA sequences coding for the RBM43 protein, leading to a loss of function. This knockout approach enables the investigation of downstream effects on gene expression profiles, cell proliferation, and apoptosis, thereby elucidating the gene's biological role. Researchers can observe phenotypic changes and biochemical pathways affected by the absence of RBM43, facilitating vital insights into its potential role as a therapeutic target.
Scientifically, these knockout cell lines are invaluable in both research and clinical contexts. They provide a foundation for studying disorders where RBM43 is hypothesized to play a critical role, such as neurodegenerative diseases and cancers. This can lead to the identification of novel biomarkers or therapeutic targets, advancing our understanding of complex pathologies.
What sets our RBM43 Gene Knockout Cell Lines apart from traditional gene editing methods is their ready-to-use format, rigorous validation processes, and comprehensive data support. These features reduce the time and effort required for experiment setup, allowing researchers to focus on their core inquiries. Furthermore, the reliability and reproducibility of our cell lines affirm their worth in critical research settings.
For researchers and clinicians aiming to unravel the intricacies of gene function and its implications in health and disease, RBM43 Gene Knockout Cell Lines represent a significant advancement in model systems. Our company specializes in high-quality biological products, with a commitment to providing innovative tools that empower discovery and enhance scientific progress, ensuring you have the best resources at your disposal for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.